Toll Free: 1-888-928-9744

Advaxis, Inc. - Product Pipeline Review - 2014

Published: Mar, 2014 | Pages: 66 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Advaxis, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Advaxis, Inc. - Product Pipeline Review - 2014', provides an overview of the Advaxis, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Advaxis, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Advaxis, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Advaxis, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Advaxis, Inc.'s pipeline products

Reasons to buy

- Evaluate Advaxis, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Advaxis, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Advaxis, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Advaxis, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Advaxis, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Advaxis, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Advaxis, Inc. Snapshot 6
Advaxis, Inc. Overview 6
Key Information 6
Key Facts 6
Advaxis, Inc. - Research and Development Overview 7
Key Therapeutic Areas 7
Advaxis, Inc. - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Advaxis, Inc. - Pipeline Products Glance 12
Advaxis, Inc. - Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
Advaxis, Inc. - Clinical Stage Pipeline Products 13
Phase I Products/Combination Treatment Modalities 13
Advaxis, Inc. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Advaxis, Inc. - Drug Profiles 16
ADXS-HPV 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
ADXS-HER2 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Adxs-LmddA159 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
ADXS-PSA 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Bivalent Therapy for Cancer 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Drug Targeting PSCA for Prostate Cancer 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Lm-LLO-CA9 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Lm-LLO-CD-105 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
Lm-LLO-CEA 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Lm-LLO-FAP 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Lm-LLO-Flk-1 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
Lm-LLO-HER2-CA9 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
Lm-LLO-HMW-MAA-C 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
Lm-LLO-IL-13R Alpha2 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
Lm-LLO-ISG-15 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
Lm-LLO-PSA-HMWMAA 46
Product Description 46
Mechanism of Action 46
R&D Progress 46
Lm-LLO-WT-1 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
Lovaxin S 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
Advaxis, Inc. - Pipeline Analysis 51
Advaxis, Inc. - Pipeline Products by Target 51
Advaxis, Inc. - Pipeline Products by Route of Administration 53
Advaxis, Inc. - Pipeline Products by Molecule Type 54
Advaxis, Inc. - Recent Pipeline Updates 55
Advaxis, Inc. - Dormant Projects 63
Advaxis, Inc. - Locations And Subsidiaries 64
Head Office 64
Appendix 65
Methodology 65
Coverage 65
Secondary Research 65
Primary Research 65
Expert Panel Validation 65
Contact Us 66
Disclaimer 66
List of Tables
Advaxis, Inc., Key Information 6
Advaxis, Inc., Key Facts 6
Advaxis, Inc. - Pipeline by Indication, 2014 8
Advaxis, Inc. - Pipeline by Stage of Development, 2014 10
Advaxis, Inc. - Monotherapy Products in Pipeline, 2014 11
Advaxis, Inc. - Phase III, 2014 12
Advaxis, Inc. - Phase I, 2014 13
Advaxis, Inc. - Preclinical, 2014 14
Advaxis, Inc. - Pipeline by Target, 2014 52
Advaxis, Inc. - Pipeline by Route of Administration, 2014 53
Advaxis, Inc. - Pipeline by Molecule Type, 2014 54
Advaxis, Inc. - Recent Pipeline Updates, 2014 55
Advaxis, Inc. - Dormant Developmental Projects,2014 63 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify